©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
The Contrahelicase Activities of the Replication Terminator Proteins of Escherichia coli and Bacillus subtilis Are Helicase-specific and Impede both Helicase Translocation and Authentic DNA Unwinding (*)

(Received for publication, August 16, 1995; and in revised form, October 2, 1995)

Trilochan Sahoo Bidyut K. Mohanty Marc Lobert Adhar C. Manna Deepak Bastia (§)

From the Department of Microbiology, Duke University Medical Center, Durham, North Carolina 27710

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES

ABSTRACT

Replication forks are arrested at sequence-specific replication termini primarily, perhaps exclusively, by polar arrest of helicase-catalyzed DNA unwinding by the terminator protein. The mechanism of this arrest is of considerable interest. This paper presents experimental evidence in support of four major points pertaining to termination of DNA replication. First, the replication terminator proteins of both Escherichia coli and Bacillus subtilis are helicase-specific contrahelicases, i.e. the proteins specifically impede the activities of helicases that are involved in symmetric DNA replication but not of those involved in conjugative DNA transfer and rolling circle replication. Second, the terminator protein (Ter) of E. coli blocks not only helicase translocation but also authentic DNA unwinding. Third, the replication terminator protein of Gram-positive B. subtilis is a polar contrahelicase of the primosomal helicase PriA of Gram-negative E. coli. Finally, the blockage of PriA-catalyzed DNA unwinding was abrogated by the passage of an RNA transcript through the replication terminator protein-terminus complex. These results are significant because of their relevance to the mechanistic aspects of replication termination.


INTRODUCTION

Specific termination sites of DNA replication exist in the plasmid R6K (1, 2, 3) and the bacteria Escherichia coli(4, 5) and Bacillus subtilis(6, 7) . Sites that arrest replication forks have also been reported in eukaryotes such as Epstein-Barr virus(8) , and in ribosomal DNAs of yeast(9, 10) , plant (11) , and humans(12) . The yeast centromeres are also known to arrest replication fork movement(13) .

In prokaryotes, the replication fork arrest is polar and is mediated by the interaction of replication terminator proteins with the terminus sequence(6, 7, 14, 15, 16) .

The replication terminator protein of E. coli (called Ter or Tus) and that of B. subtilis (called RTP) (^1)are polar contrahelicases, i.e. these proteins inhibit the activities of DnaB helicase of E. coli in only one orientation of the terminus sequence with respect to the origin(17, 18, 19, 20) . Although several groups have reported that Ter protein of E. coli(17, 21) impedes the activity of DnaB but not that of helicase II, others believe that the terminator proteins are general road blocks on DNA that block the passage of many if not all helicases(22, 23, 24) . The resolution of the question of helicase specificity of replication terminator proteins has an obvious bearing on the mechanism of the contrahelicase activity. Blocking of many helicases that are involved in other functions such as DNA repair, transcription, conjugative transfer of DNA etc., might imply that the interactions of Ter and RTP with their respective binding sites called and IR sequences (or BS3) are all that might be necessary to elicit polar impedance of helicase activity. In contrast, helicase-specific block might imply, in addition to DNA-terminator protein interaction, also helicase-terminator protein interaction. The crystal structure of RTP of B. subtilis has been solved at 2.6-Å resolution(25) . The protein has a postulated tripartite DNA binding domain that envisages contact with the minor groove of DNA by the N-terminal arm and the beta2-beta3 pleated sheets and major groove contact by the alpha3 region of the protein. The crystal structure suggests an exposed hydrophobic patch near the beta2-beta3 region as a possible surface for interaction with helicases.

The Ter protein also blocks replication forks of SV40 and antagonizes the helicase activity of the T-antigen(26, 27) . We have recently discovered that Ter and RTP interact with DnaB helicase and SV40 T-antigen. (^2)Hiasa and Marians (21) have reported that purified Ter, in vitro, can block DnaB translocation but not authentic unwinding of DNA duplex. The implication is that blocking of DNA unwinding requires the participation, along with Ter, of other proteins. Recently, we have discovered that both Ter and RTP are also polar anti-transcriptases and block RNA chain elongation by E. coli, T7, and SP6 RNA polymerases. (^3)

The present investigation was mainly driven by the need to answer two questions: (i) are the contrahelicase activities of Ter and RTP helicase-specific? and (ii) do the terminator proteins by themselves, without the assistance of other proteins, block authentic helicase-catalyzed DNA unwinding? In addition to answering the two questions posed above, the results presented in this paper also demonstrate that RTP of Gram-positive B. subtilis, impeded the activity of PriA helicase of Gram-negative E. coli. Furthermore, the PriA-blocking activity of RTP was abrogated by the passage of an RNA transcript through the terminus (BS3)-RTP complex.


MATERIALS AND METHODS

Purification of Proteins and Enzymes

Ter, DnaB(17) , and RTP (28) were purified as published. Rep helicase (29) was a generous gift from Tim Lohman (Washington University, St. Louis, MO). Single strand DNA binding protein (SSB) was from a commercial source (U.S. Biochemical Corp.). Helicase I was purified according to a modification of a published procedure(30) . The cells(N4830) containing the overproducer plasmid (pMP8) were induced, and the purification was carried out through a DEAE-Sephacel step according to the published procedure. The enzyme was then purified by successive fast flow Q-Sepharose, heparin-agarose and Mono-Q fast protein liquid chromatography close to homogeneity (see Fig. 1). All gradients for the above mentioned steps were from 0 to 0.5 M NaCl in 20 mM Tris-HCl, pH 7.8, 0.5 mM EGTA, 0.1 mM EDTA, 5 mM beta-mercaptoethanol, and 10% glycerol. T7 RNA polymerase was purified according to a published protocol(31) . The protein fractions were taken through the (NH(4))(2)SO(4) precipitation as published. The further purification involved S-Sepharose, hydroxylapatite, and a Mono-S step in sequence. PriA was purified from a pET3C-PriA overproducer clone kindly provided by Ken Marians (Memorial Sloan-Kettering Cancer Center, New York, NY) by a modification of the procedure of Shlomai and Kornberg(35) . The cells were harvested and lysed with lysozyme (1 mg/ml) in 50 mM Tris-HCl, pH 8.0, 10% sucrose, 1 mM DTT, 1 mM EDTA. The cleared lysate was precipitated with (NH(4))(2)SO(4) (0.24 gm/ml). The precipitate was spun down, dissolved in buffer A (25 mM imidazole-Cl, pH 6.8, 1 mM DTT, 1 mM EDTA, 15% glycerol, 50 mM NaCl) and dialyzed against the same buffer. The dialysate was loaded onto a Bio-Rex 70 column equilibrated with buffer A. After washing, the protein was eluted with 10 column volumes of a gradient of 0.05-1 M NaCl in the same buffer. The peak containing PriA (monitored by a 10% SDS-polyacrylamide gel) was dialyzed against buffer B (25 mM imidazole-Cl, pH 6.8, 1 mM DTT, 1 mM EDTA, 15% glycerol), loaded onto a P11-phosphocellulose column, and washed with buffer B. The protein was eluted with a 0-0.75 M NaCl gradient, and peak fractions were pooled and dialyzed against buffer C (25 mM imidazole-Cl, pH 6.8, 5 mM potassium phosphate, 1 mM DTT, 1 mM EDTA, 20% glycerol, 25 mM (NH(4))(2)SO(4)) and loaded onto a hydroxylapatite column equilibrated with buffer C. The column was washed and eluted with a 20-400 mM linear (NH(4))(2)SO(4) gradient in buffer C. The peak fractions were pooled and dialyzed against buffer D (25 mM imidazole-Cl pH 6.8, 1 mM DTT, 1 mM EDTA, 10% glycerol, 25 mM NaCl) onto a Mono-S FPLC column. The protein was eluted with a 0.025-1 M NaCl gradient in buffer D. The PriA thus obtained was >95% pure (Fig. 1).


Figure 1: SDS-Polyacrylamide gel showing the purity of the proteins prepared and used in the various experiments. Lane A, helicase I; lane B, T7 RNA polymerase; lane C, Rep helicase; lane D, PriA helicase; lane E, DnaB; lane F, Ter protein; lane G, RTP; lane M, molecular mass markers. Lanes A-G contained 10 µg of each protein.



Helicase Substrates

Single-stranded M13 mp18 or mp19 containing the Ter-binding () or RTP-binding (BS3) site in opposite orientations served as the template for preparation of various helicase substrates (diagrammatic representations in the top panel of Fig. 4Fig. 5Fig. 6, and 8). Radiolabeled (P) complementary oligonucleotides (to or BS3 site) were annealed to the specific M13 or M13BS3 single-stranded DNA, and after purifying through Sepharose CL-4B columns were used for standard helicase assays. Substrates containing extended primer across the interstitially located or BS3 site were prepared by annealing an 18-mer oligonucleotide about 130 bases downstream of the site and extending with Sequenase (modified T7 DNA polymerase, USB) in the presence of [alphaP]dATP and ddATP. This provides a mixture of extension products forming heteroduplex regions of varying lengths. For assaying PriA helicase, the recombinant M13 single-stranded DNA was constructed with a primosome assembly site (PAS) downstream of the BS3 site to enable PriA helicase to move in a 3` 5` direction toward the BS3 site. A P-end-labeled oligonucleotide complementary to the BS3 site was annealed to the specific single-stranded DNA template, and the resulting substrate was used for the helicase assay with PriA. Substrate for T7 RNA polymerase-mediated release of PriA block by RTP was same as that for PriA assay except that a T7 RNA polymerase promoter was cloned upstream of BS3 site oriented such that RNA chain synthesis proceeded toward the BS3 site. The orientation of the BS3 site in this substrate was such that RTP-BS3 complex would block PriA activity but not T7 RNA polymerase movement and RNA chain elongation (Fig. 8, top panel). An oligonucleotide complementary to the BS3 site was annealed to the single-stranded DNA and extended with Sequenase (modified T7 DNA polymerase, U.S. Biochemical Corp.) in the presence of dNTPs, [alpha-P]dATP, ddCTP, and ddGTP to give partial duplex substrate of various lengths.


Figure 4: Autoradiogram of an 8% polyacrylamide gel showing response of helicase I-mediated DNA unwinding to increasing concentrations of Ter protein. Substrate for helicase assay with extended heteroduplex region across the site in M13 mp18 and M13 mp19 was prepared as depicted in the figure (top panel). Lane M`, double-stranded DNA marker; lane A, mp18 without helicase I and without Ter; lanes B-E, mp18 with helicase I and increasing concentrations of Ter (0, 0.2, 0.4, and 0.8 pmol); lane F, mp19 without helicase I and without Ter; lanes G-J, mp19 with helicase I and increasing concentrations of Ter (0, 0.2, 0.4, and 0.8 pmol); lane K, mp18 with DnaB only; lane L, mp18 with DnaB and 0.4 pmol of Ter; lane M, mp19 with DnaB only; lane N, mp19 with DnaB and 0.4 pmol of Ter. Note there was no blockage of Helicase I activity in either orientation by Ter in contrast to polar blockage of DnaB activity (positive controls).




Figure 5: Polar blockage of PriA helicase by RTP-BS3 complex. M13 mp18BS3PAS and M13 mp18BS3revPAS with the RTP binding site in opposite orientations with regard to PriA movement were constructed as depicted in panel A. A 53-mer oligonucleotide complementary to the BS3 site with a 3` overhang was annealed to the single-stranded DNA, and standard helicase assays were performed after binding RTP to the BS3 site. BS3 and BS3rev are two orientations of the replication terminus of B. subtilis. The arrow ending with a vertical line indicates the orientation of BS3 that blocks a given helicase (panel A). Panel B (top): lane A, mp18BS3PAS substrate without PriA and without RTP; lanes B and C, mp18BS3PAS with DnaB and 0 and 0.4 pmol of RTP; lane D, mp18BS3PAS substrate boiled; lanes E-I, mp18BS3PAS with 40 fmol of PriA and increasing concentrations of RTP (0, 0.1, 0.2, 0.4, and 0.8 pmol, respectively). Panel B (bottom): lane A, mp18BS3revPAS substrate without PriA and without RTP; lanes B and C, mp18BS3revPAS with DnaB and 0 and 0.4 pmol of RTP; lane D, mp18BS3revPAS boiled substrate; lanes E-I, mp18BS3revPAS with 40 fmol of PriA and increasing concentrations of RTP (0, 0.1, 0.2, 0.4, and 0.8 pmol). Note polar blockage of PriA by RTP in one orientation (mp18BS3revPAS) and DnaB in the other (mp18BS3PAS). Panel C, quantitation of the data presented in the autoradiogram shown in panel B. The radioactivity present in each band was measured with a PhosphorImager. Note the polar block of PriA of E. coli by the RTP of B. subtilis.




Figure 6: Autoradiogram of a nondenaturing 6% polyacrylamide gel showing polar contrahelicase activity of Ter protein independent of the length of the double-stranded region in a heteroduplex containing interstitially located Ter-binding site (). Top, the helicase substrates with M13 mp18 (Ter-active) and M13 mp19 (Ter-inactive) templates were constructed as described in the figure. Bottom: lane M, double-stranded DNA marker; lane A, boiled M13 mp18 substrate; lane B, M13 mp18 without Ter and without DnaB proteins; lanes C-G, M13 mp18 substrate with 400 ng of DnaB and increasing amounts of Ter protein (0, 0.4, 0.8, 1.2, and 1.6 pmol, respectively); lane H, boiled M13 mp19 substrate; lanes I-N, M13 mp19 substrate with 400 ng of DnaB and increasing amounts of Ter protein (0, 0.4, 0.8, 1.2, and 1.6 pmol). Note that Ter- complex blocks DnaB-catalyzed unwinding of heteroduplex DNA containing the Ter binding site in a polar fashion and is independent of the size of the oligonucleotide.




Figure 8: Coupled helicase transcription assay to show that PriA helicase block by RTP can be abrogated by RNA polymerase invading the RTP-BS3 complex. An M13 mp18BS3rev-T7Pr substrate was constructed with RTP binding site (BS3) and T7-RNA polymerase promoter oriented such that RTP-BS3 complex was in the blocking orientation with regard to PriA helicase movement and in the nonblocking orientation with regard to RNA polymerase movement on the same heteroduplex substrate. Lane A, substrate with 200 fmol of PriA only; lane B, substrate with 200 fmol of PriA and 100 fmol of T7 RNA polymerase; lanes C and D, substrate with 200 fmol of PriA and increasing concentrations of RTP (1.6 and 2.0 pmol); lanes E and F, substrate with 200 fmol of PriA, 1.6 pmol of RTP, 50 and 100 fmol of T7 RNA polymerase, respectively; lanes G and H, substrate with PriA, 2.0 pmol of RTP, and 50 and 100 fmol of T7 RNA polymerase. Note the drastic blockage of PriA activity by RTP (lanes C and D) and the significant release of the block by RNA polymerase invasion into and movement across the RTP-BS3 complex (lanes E-H).



Helicase Assay

Standard reaction mixture (in a total volume of 20 µl) for DnaB, Helicase I, and Rep helicase contained 10 fmol of the DNA substrate in 50 mM Tris-HCl pH 7.5, 4 mM MgCl(2), 2 mM ATP, 50 mM potassium glutamate, 50 µg/ml BSA, and 5 mM DTT. Indicated amounts of Ter or RTP were added to the substrate and placed on ice (in the case of Ter) or at room temperature (in the case of RTP) for 15-20 min. After adding the helicase (DnaB, Rep, Helicase I, or PriA) the mixture was incubated at 37 °C for 10 min (in case of Helicase I, Rep, and PriA) or 15 min (for DnaB). Reactions were terminated by the addition of dye mixture containing SDS-EDTA-sucrose and bromophenol blue. Analysis was done by electrophoresis through 6-8% polyacrylamide gel in Tris borate-EDTA buffer and autoradiography with Kodak XAR film. The percentage of oligonucleotide released was quantitated by PhosphorImager analysis or by Cerenkov counting of radioactivity present in the bands excised from the gel after autoradiography. For PriA helicase assay the reaction mixture contained, in addition to the above components, 0.5 µg of SSB/reaction. Mapping of the minimal effective terminator sequence required for Ter protein to bind and block DnaB-mediated oligo release was done by eluting the released bands in the helicase assay (bracket and arrow in Fig. 6) and resolving it in a sequencing gel alongside a sequence ladder generated by the same oligo single-stranded DNA template. The coupled helicase transcription assay (PriA-T7 RNA polymerase) was carried out in a reaction mixture containing 40 mM Tris-HCl, pH7.5, 4 mM MgCl(2), 2 mM ATP, 0.5 mM each of CTP, UTP, GTP, 50 mM potassium glutamate, 5 mM DTT, and 50 µg/ml BSA in a total reaction volume of 20 µl. After incubation of RTP with the heteroduplex substrate at room temperature for 15 min, indicated amounts of T7 RNA polymerase and PriA were added and incubated at 37 °C for 20 min. Analysis was done on a 30-cm-long 8% polyacrylamide gel.


RESULTS

Replication Terminator Proteins Are Helicase-specific Contrahelicases

The experiments described in this section were conducted to answer the following question. Do the terminator proteins act as polar clamps on DNA that block almost any helicase that translocates on DNA, or is the block helicase-specific, implying specific recognition of replicative helicases by both Ter and RTP? Previous work had established the fact that Ter (Tus) protein of E. coli(17, 18) and RTP of B. subtilis(19, 20) impede the activity of the E. coli replicative helicase, DnaB. We wished to investigate, using a wide range of concentrations of other helicases and the two terminator proteins, whether non-replicative helicases, i.e. Helicase I and Rep helicase, are impeded by RTP and Ter. Non-replicative helicases are helicases that are not involved in Cairns-type or symmetric DNA replication. The purities of the various enzymes and proteins used in the experiments described in this paper are shown in Fig. 1. In the first series of experiments we kept the molar concentration of Rep helicase at 400 fmol (58 ng) and varied the molar ratios of RTP over the DNA substrate from 40 to 160. DnaB helicase was used as a positive control. The helicase substrate contained the terminus of B. subtilis called BS3 (IRI) in both orientations with respect to the direction of the helicase translocation. The results shown in the autoradiogram and its quantitative analysis (Fig. 2, top) revealed that under the wide range of experimental conditions used, RTP failed to block DNA unwinding by Rep helicase. In contrast DnaB was blocked in a polar fashion (Fig. 2, top left, lanes M and N). Similar experiments performed using Ter protein gave identical results (data not shown). We also performed helicase assays using a fixed amount (100 fmol = 18 ng) of helicase I and a wide range of ratios of Ter to DNA substrate(50-300). The results again showed that helicase I was not impeded by Ter (Fig. 2, lower panel). Similar experiments were also performed with RTP and yielded similar results (data not shown). Thus neither Ter nor RTP impeded the catalytic activity of Helicase I when bound to the respective terminator sequences present in either orientation.


Figure 2: Autoradiogram showing the effect of RTP-B53 complex and -ter complex on the activity of Rep and helicase I, respectively. The concentrations of helicase I and Rep were kept constant at 100 fmol (18 ng) and 400 fmol (58 ng), respectively. The substrates were M13 mp19BS3/ and M13 mp18BS3/ DNAs that were heteroduplexed at the BS3 or the sites with a 5` end-labeled oligonucleotide. Top left panel: lane A, mp19BS3 substrate without RTP and without Rep; lanes B-F, mp19BS3 with 400 fmol of Rep and 0, 0.4, 0.8, 1.2, and 1.6 pmol of RTP respectively; lane G, mp18BS3 substrate without RTP and without Rep; lanes H-L, mp18BS3 with 400 fmol of Rep and 0, 0.4, 0.8, 1.2, and 1.6 pmol of RTP, respectively; lanes M-N, mp19BS3 with DnaB and 0 and 0.4 pmol of RTP, respectively. Note that there is no detectable impedence of Rep helicase activity by RTP-BS3 complex in either orientation, whereas DnaB activity is impeded. Top right panel, the radioactivity present in each band shown in the top left, was quantitated with a PhosphorImager and plotted. The quantitations confirm the conclusion stated above. Bottom left panel: lane A, mp19 substrate without Ter and helicase I; lanes B-H, mp19 with 100 fmol of helicase I and 0, 0.5, 1.0, 1.5, 2.0, 2.5, and 3.0 pmol of Ter, respectively; lane I, mp18 without Ter and without helicase I; lanes J-P, mp18 with 100 fmol of Helicase I and 0, 0.5, 1.0, 1.5, 2.0, 2.5, and 3.0 pmol of Ter, respectively. Note there is no detectable blockage of helicase I activity by Ter in either orientation of . Bottom right panel, the bands shown in the bottom left panel were quantitated with a PhosphorImager and plotted. The data support the conclusion made above.



In view of the reports in the literature that terminator proteins block many helicases(18, 24) , we wished to confirm our observations by keeping the concentrations of RTP and Ter constant and changing the ratios of helicase I to the substrate over a wide range. The helicase assays again showed that neither the activity of Rep helicase (molar ratios of 5-40; RTP 40-fold molar excess over DNA substrate) or of helicase I (molar ratio of enzyme over substrate 5-60; RTP present in 40-fold molar excess over substrate) was impeded by RTP (Fig. 3). Similar experiments performed with Ter protein, helicase I, and Rep helicase yielded identical results (data not shown). Thus neither RTP nor Ter were able to impede the catalytic activities of helicase I and Rep helicase over a wide range of experimental conditions.


Figure 3: The activities of both helicase I and Rep helicase are not impeded by RTP. The RTP concentration was kept fixed (RTP:substrate = 40:1), but the Rep and helicase I concentrations were varied over a wide range. Top left and right panels, the activity of Rep helicase was not impeded over a wide range of concentrations of the helicase (molar excess of enzyme to substrate up to 40-fold) in both orientations of the terminus of B. subtilis (BS3). Bottom left and right panels, the activity of helicase I was not impeded by RTP (kept constant at a concentration of protein:substrate = 40:1) over a wide range of concentrations of helicase I (helicase:substrate up to 60:1) in either orientation of the terminus.



We endeavored to test whether Ter (or RTP) might block the activity of Helicase I on a DNA substrate that had a heteroduplex region of only a certain length. Using an oligonucleotide primer and the circular single-stranded DNA of M13 mp18/19 we generated a population of DNA substrates that contained various lengths of heteroduplex regions from <100 bp to >2000 bp (Fig. 4, top). We performed helicase assays in the absence and presence of various concentrations of Ter. DnaB helicase was used as a positive control. The results showed that whereas DnaB was impeded in a polar fashion by Ter (Fig. 4, bottom, lanes k and l), the activity of helicase I was not impeded, regardless of the length of the heteroduplexed region present in the substrate (Fig. 4, lanes B-E, and G-J), and in both orientations of the sequence.

RTP Impedes the Activity of PriA Helicase in a Polar Mode

To extend our previous observation that RTP of Gram-positive B. subtilis blocks the replicative helicase DnaB of Gram-negative E. coli(19, 20) , we wished to test whether RTP also impedes the activity of PriA helicase of E. coli. PriA translocates in a 3` 5` direction on DNA, unlike DnaB that moves in a 5` 3` direction(21, 32) . We constructed a helicase substrate that had a PAS (Fig. 5A) and the BS3 site in both orientations (BS3 and BS3rev). The helicase assays showed that RTP of B. subtilis failed to block the activity of PriA on the BS3 substrate; DnaB activity in contrast was impeded (Fig. 5B, top). However, in the BS3rev substrate, RTP impeded the helicase activity of PriA but not of DnaB (Fig. 5B, bottom). The quantitation of the autoradiogram shown (in Fig. 5B) is shown in Fig. 5C. Thus a 20-fold molar excess of RTP over DNA substrate was able to block, in a polar fashion, the activity of 40 fmol of PriA.

The Ter Protein, Unaided by Other Replication Proteins, Can Block Not Only Helicase Translocation but Also Authentic DNA Unwinding

Previous work by Hiasa and Marians (21) had suggested that the Ter (Tus) protein, unaided by other replisomal proteins, was able to block DnaB translocation but not authentic unwinding of long stretches of double-stranded DNA (>250 bp). The conclusions of Hiasa and Marians (21) were based on the observation that Ter by itself could impede the DnaB-catalyzed unwinding of short DNA duplexes of up to 100 bp but failed to block the unwinding of duplexes over 250 bp and, secondly, that the half-maximal concentration of ATP required for unwinding of short duplexes was the same as that needed for DnaB translocation. In contrast the half-maximal concentration of ATP required for DnaB-catalyzed unwinding was 10-fold more than that needed for enzyme translocation. The implication was that Ter by itself can not block helicase-catalyzed unwinding ahead of a replication fork but needed the assistance of other proteins for this activity. We wished to reexamine this point by constructing helicase substrates that had a wide range of lengths of double-stranded DNA that include the terminus in both orientations. We used M13 mp18/19, single-stranded DNA circles with a primer that was extended in the presence of a dideoxynuleotide triphosphate (ddNTP) and [alpha-P]dATP and T7 DNA polymerase. A set of extension products, ranging in length from 50 to >1500 nucleotides was thus generated (Fig. 6, top). The two sets of substrates M13 mp18/19 thus generated were incubated with DnaB and ATP in the absence and presence of a range of concentrations of Ter protein. The results showed that, in the M13 mp18 substrates, all the extension products that had stopped short of the sequence were released by DnaB, whereas all DNA chains that included , ranging in length from 150 to greater than 1500 bp, were blocked from release by DnaB, thus generating a ``footprint'' of release (Fig. 6, bottom, lanes C-G). In contrast, in the M13 mp19 substrate, Ter protein was unable, as expected, to block DnaB activity, and a ladder of products from 50 to >1500 nucleotides were released (Fig. 6, bottom, lanes I-N). These experiments showed that there was no length dependence of Ter in its ability to impede DnaB activity in a polar fashion. Thus, we concluded that Ter protein by itself was capable of impeding both DnaB translocation and duplex unwinding, unaided by any other replisomal proteins.

The Minimal Effective Sequence of That Promotes Contrahelicase Activity

The ``helicase activity footprint'' described above provided us with an approach to determine the minimum critical nucleotide sequence of that, when present in the double-stranded form, could elicit contrahelicase activity of Ter. The experiment described in Fig. 6was performed separately, using all four ddNTPs, and the regions marked by the bracket (Fig. 6, bottom) were eluted and resolved in a sequencing gel with appropriate sequencing ladder as markers. This experiment allowed us to determine the precise right boundary of a ``minimal effective length'' of the sequence (Fig. 7, top). Thus the extended primer had to copy the critical T residue on the template, thus generating the complementary sequence 5`-ACTTTAGTTACAACATA-3` to be able to elicit contrahelicase activity. All extension products short of the last A residue failed to elicit contrahelicase activity of the Ter protein (Fig. 7, bottom).


Figure 7: Autoradiogram showing precise right boundary of the minimum effective terminator sequence required for Ter protein to bind and mediate contrahelicase activity with respect to DnaB. Lanes a, c, g, and t represent extended primer across the site effectively released by DnaB in the presence of Ter protein (shown by bracket and arrow in Fig. 6). Lanes A, C, G, and T are sequence ladder across site generated using the same primer used for extension and helicase assay. Note when chain extension (i.e. heteroduplex region) is beyond the ``T'' at the 3` end (bracketed) of the sequence shown in the bottom panel, Ter protein is able to effectively block DnaB activity in a polar fashion (lanes D-G in Fig. 6).



The Contrahelicase Activity of RTP against PriA Helicase Is Abrogated by an Invading RNA Transcript

We have previously shown that Ter and RTP are also DNA sequence-specific anti-transcriptases, i.e. the proteins are able to block, in a polar fashion, RNA chain elongation by several prokaryotic RNA polymerases.^3 We have also shown that the contrahelicase activity of Ter and RTP directed against DnaB, that translocates in a 5`->3` direction on DNA, is abrogated by an invading RNA transcript.^3 We wished to examine if RNA transcription would have the same effect on the ability of RTP to impede a helicase that translocates in the 3` 5` direction, i.e. PriA. We constructed a set of substrates by primer extension on the M13 mp18BS3rev template that included a PAS as shown in Fig. 8(top). The substrate included a T7 promoter capable of directing a RNA transcript clockwise into the BS3rev terminus. The family of partial heteroduplexed substrates was coated with SSB, and helicase assays were performed with purified PriA. The results showed that PriA, in the presence of ATP was able to unwind the DNA, thus releasing a ladder of extension products (Fig. 8, bottom, lanes A and B). RTP blocked the release of the ladder (Fig. 8, bottom, lanes C and D). Turning on the T7 promoter by including T7 RNA polymerase in the reaction mixture abrogated the arrest of PriA at the BS3 site, thus releasing the ladder of extension products (Fig. 8, bottom, lanes E-H). Thus the contrahelicase activity of RTP directed against PriA is abrogated by an invading RNA transcript that propagated through the terminus sequence.


DISCUSSION

Although there is general agreement that Ter imposes a polar block on DnaB-catalyzed DNA unwinding, whether or not Ter is also a general helicase blocker has been a debatable issue(17, 18, 21, 24) . The resolution of this issue should have significant implications for the understanding of the mechanism by which terminator proteins block replication forks, i.e. a block imposed strictly by terminator protein terminus-DNA interaction versus specific protein-protein interaction between the replicative helicase(s) and the terminator protein.

We have critically examined this issue using the replicative primosomal helicase PriA of E. coli and the Rep helicase and Helicase I of E. coli as representatives of non-replicative helicases. Non-replicative helicases implies those that do not participate in symmetric or ``Cairns type'' DNA replication. It is worth remembering that Helicase I is involved in conjugational DNA transfer, whereas Rep helicase is involved in rolling circle DNA replication of the X174 family of phages(33, 34) .

We have found that RTP of B. subtilis acted as a polar contrahelicase of PriA, thus complementing our earlier results with DnaB of E. coli(19, 20) . In contrast, we detected no blockage of either Rep or Helicase I by Ter or RTP over a wide range of terminator-to-substrate and helicase-to-substrate ratios. Thus we could not confirm an earlier report claiming polar blockage of Helicase I by Ter protein(23) . On the basis of our results reported in this paper, we believe that Ter and RTP are specific contrahelicases of the replicative helicases DnaB and PriA, and in the case of Ter, of T antigen of SV40(23, 26, 27) . Implicit in these results is the idea that the arrest of replication forks at the terminus involves specific interaction between replicative helicase and terminator protein(s). Consistent with this notion is our recent discovery that a point mutation at a residue believed to be in the helicase blocking domain of RTP, as suggested from its crystal structure(25) , does not interfere with DNA binding but abolishes the ability of the resultant RTP to block DnaB helicase. (^4)

A second issue addressed in this paper is whether Ter, unaided by any other protein, can block authentic, helicase-catalyzed DNA unwinding. Our results conclusively show that over a wide range of 50 to greater than 1500 bp of duplex DNA, DNA unwinding by DnaB is abolished by Ter, thus complementing our earlier results with RTP(20) . Thus we were unable to confirm the conclusions of Hiasa and Marians (21) that Ter by itself can block helicase translocation but not authentic DNA unwinding.

We have reported that invasion of a terminus, in vitro, by an RNA transcript, released arrested PriA helicase. This observation provides further support of our proposition that transcriptional invasion of a replication terminus is detrimental to the termination process. The RNA transcripts are halted before entering the terminus by the RNA chain anti-elongation activity of RTP and Ter^3 in a polar fashion.

The Ter protein of E. coli and RTP of B. subtilis bear little or no homology in the primary amino acid sequence, yet both proteins block the same replicative helicases of E. coli, namely DnaB and PriA(17, 19, 20) . On the basis of crystallography of RTP and mutational analysis, there are already preliminary indications of the surface of RTP that is involved in helicase blocking.^4 Although Ter protein has been refractory to crystallization, mutational analysis of its coding region should enable one to localize the helicase-blocking region of the protein. Future work will be directed at localizing the RNA polymerase-blocking domain on RTP and Ter as well as the interaction surface on DnaB that recognizes Ter and RTP. Such studies should illuminate further the mechanism of replication termination.


FOOTNOTES

*
This work was supported by National Institutes of Health Grant GM 49264 (to D. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
To whom all correspondence should be addressed. Tel.: 919-684-3521; Fax: 919-684-8735.

(^1)
The abbreviations used are: RTP, replication terminator protein; SSB, single strand DNA binding protein; DTT, dithiothreitol; bp, base pair; PAS, primosome assembly site.

(^2)
B. K. Mohanty and D. Bastia, manuscript in preparation.

(^3)
B. K. Mohanty, T. Sahoo, and D. Bastia, manuscript in preparation.

(^4)
A. Manna, S. Pai, and D. Bastia, manuscript in preparation.


ACKNOWLEDGEMENTS

We thank Drs. Steve Matson and Tim Lohman for initial supplies of Helicase I and Rep helicase, respectively, and for the overproducer strains for these enzymes. We also thank Drs. Ken Marians and Alan Rosenberg for providing us with the overproducer strains for PriA and T7 RNA polymerase, respectively. We thank Ocie Ingram for the preparation of this manuscript.


REFERENCES

  1. Bastia, D., Germino, J., Crosa, J. H., and Ram, J. (1981) Proc. Natl. Acad. Sci. U. S. A. 78, 2095-2099 [Abstract]
  2. Crosa, J. H., Luttrop, L., and Falkow, S. (1976) J. Bacteriol. 126, 454-466 [Medline] [Order article via Infotrieve]
  3. Kolter, R., and Helinski, D. R. (1978) J. Mol. Biol. 124, 425-441 [Medline] [Order article via Infotrieve]
  4. Kuempel. P. L., Duerr, S. A., and Seely, N. R. (1977) Proc. Natl Acad. Sci. U. S. A. 74, 3927-3931 [Abstract]
  5. Louarn, J., Patte, F., and Louarn, J. M. (1977) J. Mol. Biol. 115, 295-314 [Medline] [Order article via Infotrieve]
  6. Carrigan, C. M., Peck, R. A., Smith, M. T., and Wake, R. G. (1991) J. Mol. Biol. 222, 197-207 [Medline] [Order article via Infotrieve]
  7. Smith, M. T., and Wake, R. G. (1992) J. Mol. Biol. 227, 548-657
  8. Gahn, T. A., and Schildkraut, K. (1989) Cell 23, 681-687
  9. Brewer, B. J., Lockshon, D., and Fangman, W. (1992) Cell 71, 267-276 [Medline] [Order article via Infotrieve]
  10. Linskens, M. H. K., and Huberman, J. A. (1988) Mol. Cell. Biol. 8, 4927-4935 [Medline] [Order article via Infotrieve]
  11. Hernandez, P., Lamm, S. S., Bjerkness, C. A., and Vant'hof, J. (1986) EMBO J. 7, 303-308
  12. Little, R. D., Platt, T. H., and Schildkraut, K. (1993) Mol. Cell. Biol. 13, 6600-6613 [Abstract]
  13. Greenfeder, S. A., and Newlon, C. S. (1992) Mol. Cell. Biol. 12, 4056-4066 [Abstract]
  14. Hill, T. M., Pelletier, A. J., Tecklenburg, M. L., and Kuempel, P. L. (1988) Cell 55, 459-466 [Medline] [Order article via Infotrieve]
  15. Sista, P. R., Mukherjee, S., Patel, P., Khatri, G. S., and Bastia, D. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 3026-3033 [Abstract]
  16. Sista, P. R., Hutchison, C. A., and Bastia, D. (1991) Genes & Dev. 5, 74-82
  17. Khatri, G. S., MacAllister, T., Sista, P. R., and Bastia, D. (1989) Cell 59, 667-674 [Medline] [Order article via Infotrieve]
  18. Lee, E. H., Kornberg, A., Hidaka, M., Kobayashi, T., and Horiuchi, T. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 9104-9108 [Abstract]
  19. Kaul, S., Mohanty, B. K., Sahoo, T., Patel, I., Khan, S. A., and Bastia, D. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 11143-47 [Abstract/Free Full Text]
  20. Sahoo, T., Mohanty, B. K., Patel, I., and Bastia, D. (1995) EMBO J. 14, 619-628 [Abstract]
  21. Hiasa, H., and Marians, K. (1992) J. Biol. Chem. 267, 11379-11385 [Abstract/Free Full Text]
  22. Lee, E. H., and Kornberg, A. (1992) J. Biol. Chem. 267, 8778-8784 [Abstract/Free Full Text]
  23. Hidaka, M., Kobayashi, T., Ishimi, Y., Seki, M., Enomoto, T., Abdel-Monem, M., and Horiuchi, T. (1992) J. Biol. Chem. 267, 5361-5365 [Abstract/Free Full Text]
  24. Baker, T. A. (1995) Cell 80, 521-524 [Medline] [Order article via Infotrieve]
  25. Bussiere, D. E., Bastia, D., and White, S. (1995) Cell 80, 651-660 [Medline] [Order article via Infotrieve]
  26. Bedrosian, C., and Bastia, D. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 2618- 2622 [Abstract]
  27. Amin, A. A., and Hurwitz, J. (1992) J. Biol. Chem. 267, 18612-18622 [Abstract/Free Full Text]
  28. Mehta, P. P., Bussiere, D. E., Hoffman, D. W., Bastia, D., and White, S. (1992) J. Biol. Chem. 267, 18885-18889 [Abstract/Free Full Text]
  29. Lohman, T. M., Chao, K., Green, J. M., Sage, S., and Runyon, G. (1989) J. Biol. Chem. 264, 10139-10147 [Abstract/Free Full Text]
  30. Dash, P. K., Traxler, B. A., Panicker, M. M., Hackney, D. D., and Minkley, E. G. (1992) Mol. Microbiol. 6, 1163-1172 [Medline] [Order article via Infotrieve]
  31. Grodberg, J., and Dunn, J. J. (1988) J. Bacteriol. 170, 1245-1253 [Medline] [Order article via Infotrieve]
  32. LeBowitz, J., and McMacken, R. (1986) J. Biol. Chem. 261, 4738-4748 [Abstract/Free Full Text]
  33. Lohman, T. M. (1992) Mol. Microbiol. 6, 5-14 [Medline] [Order article via Infotrieve]
  34. Matson, S. W., and Kaiser-Rogers, K. A. (1990) Annu. Rev. Biochem. 59, 289-329 [CrossRef][Medline] [Order article via Infotrieve]
  35. Shlomai, J., and Kornberg, A. (1980) J. Biol. Chem. 255, 6789-6793 [Abstract/Free Full Text]

©1995 by The American Society for Biochemistry and Molecular Biology, Inc.